Get the app!
Back to Trades

Aggarwal Gaurav

DirectorCIK 0001551965

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
2
Buy transactions
0
Sell transactions
0
Companies
1
Active
2025

Aggarwal Gaurav, Director, has filed 2 SEC reports (2025), all concentrated in Unicycive Therapeutics, Inc. (UNCY), totaling $115.5K in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

2 loaded
Aug 26UNCY
Unicycive Therapeutics, Inc.
Aggarwal GauravDirectorConversion$15.7K
Jul 30UNCY
Unicycive Therapeutics, Inc.
Aggarwal GauravDirectorAward$99.9K

2 filings